OLIGONUCLEOTIDE SEQUENCES AIMED AT THE TRANSCRIPTION FACTOR TSC22D4, FOR TREATING INSULIN RESISTANCE

• 收藏
• 分享

专利权人:

发明人:

申请号：

RU2017131900

公开号：

RU2017131900A3

申请日:

申请国别(地区):

RU

年份:

2019

代理人:

摘要：

The present invention relates to oligonucleotide inhibitors of the TSC22D4 activity or expression and their uses for the prevention, treatment, and/or regulation of insulin resistance, metabolic syndrome and/or diabetes and/or for improving insulin sensitivity in a mammal.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/